Dec 23 (Reuters) - Novo Nordisk shares jumped ‌10% ​on Tuesday after the U.S. Food and ‌Drug Administration approved its weight-loss pill, giving the Danish drugmaker a competitive edge over rival ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback